NasdaqCM - Nasdaq Real Time Price USD

Organovo Holdings, Inc. (ONVO)

Compare
0.4523 0.0000 (0.00%)
At close: October 31 at 4:00 PM EDT
Loading Chart for ONVO
DELL
  • Previous Close 0.4523
  • Open 0.4462
  • Bid 0.3784 x 100
  • Ask 0.5157 x 100
  • Day's Range 0.4400 - 0.4523
  • 52 Week Range 0.4000 - 2.0500
  • Volume 32,185
  • Avg. Volume 62,853
  • Market Cap (intraday) 6.95M
  • Beta (5Y Monthly) 0.61
  • PE Ratio (TTM) --
  • EPS (TTM) -1.3700
  • Earnings Date Nov 7, 2024 - Nov 11, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 6.10

Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised of mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company's lead candidate is FXR314, which is phase 2/3clinical trial for indication of inflammatory bowel disease with a clinical focus on ulcerative colitis; and completed phase 1 clinical trial for the indication of liver fibrosis with a clinical focus steatohepatitis. Organovo Holdings, Inc. has research collaborations with Yale School of Medicine, Knight Cancer Institute at Oregon Health & Science University, and the University of Virginia for research of NovoGen Bioprinters. The company was incorporated in 2007 and is headquartered in San Diego, California.

www.organovo.com

20

Full Time Employees

March 31

Fiscal Year Ends

Recent News: ONVO

View More

Performance Overview: ONVO

Trailing total returns as of 10/31/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ONVO
59.25%
S&P 500
19.62%

1-Year Return

ONVO
56.92%
S&P 500
36.93%

3-Year Return

ONVO
92.72%
S&P 500
23.89%

5-Year Return

ONVO
92.20%
S&P 500
87.26%

Compare To: ONVO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ONVO

View More

Valuation Measures

Annual
As of 10/31/2024
  • Market Cap

    6.95M

  • Enterprise Value

    2.05M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    65.87

  • Price/Book (mrq)

    1.04

  • Enterprise Value/Revenue

    28.05

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -73.67%

  • Return on Equity (ttm)

    -151.72%

  • Revenue (ttm)

    73k

  • Net Income Avi to Common (ttm)

    -13.99M

  • Diluted EPS (ttm)

    -1.3700

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    6.19M

  • Total Debt/Equity (mrq)

    19.29%

  • Levered Free Cash Flow (ttm)

    -7.39M

Research Analysis: ONVO

View More

Company Insights: ONVO

Research Reports: ONVO

View More

People Also Watch